George Sflomos
@georgesflomos.bsky.social
Cancer Researcher passionate about Lobular Carcinoma, Preclinical Oncology, Discovery Science & Advocacy @LobularBCA, EACR ECR Council Member @helloeacr.bsky.social
Pinned
George Sflomos
@georgesflomos.bsky.social
· Feb 28
This month we express gratitude to the six presenters who contributed to our highlights presentation of the 2024 ILC Symposium. LBCA SAB members Dr. Muhktar and Dr. Sflomos plus Dr. Covington, Lounes Djerroudi, Dr. Di Meglio and Dr. Sandoval #volunteerappreciation #lobularbreastcancer #ilc
I’m honored to have contributed to the highlights presentation of the 2024 ILC Symposium alongside an incredible group of researchers. Thank you to the organizers [email protected] I am grateful to be part of this effort to raise awareness and drive progress in lobular breast cancer!
Reposted by George Sflomos
Did you make a connection at #EACR2026? 👀⬇️
Don't forget that the EACR-Worldwide Cancer Research Collaboration Fellowships are a new initiative this year. If you make a new research connection at EACR 2026, apply for funding to continue the collaboration with an in-person visit!
Apply by 3 Sep 2026 eacr.org/collaboratio...
Apply by 3 Sep 2026 eacr.org/collaboratio...
June 11, 2026 at 1:12 PM
Did you make a connection at #EACR2026? 👀⬇️
Reposted by George Sflomos
What a wonderful week we’ve had here together in Budapest for #EACR2026! Thank you to everyone who attended, presented at and helped organise this fantastic event.
Sign up here for updates about EACR 2027 in Bilbao… 👀 eacr.us5.list-manage.com/subscribe?u=...
Sign up here for updates about EACR 2027 in Bilbao… 👀 eacr.us5.list-manage.com/subscribe?u=...
June 11, 2026 at 2:30 PM
What a wonderful week we’ve had here together in Budapest for #EACR2026! Thank you to everyone who attended, presented at and helped organise this fantastic event.
Sign up here for updates about EACR 2027 in Bilbao… 👀 eacr.us5.list-manage.com/subscribe?u=...
Sign up here for updates about EACR 2027 in Bilbao… 👀 eacr.us5.list-manage.com/subscribe?u=...
Amazing session! Congrats for the active participation!
We’re so proud to showcase the next wave of talent in cancer research at our ‘Cancer Researchers to watch’ early career showcase yesterday and this morning. #EACR2026
June 11, 2026 at 6:45 AM
Amazing session! Congrats for the active participation!
Reposted by George Sflomos
We’re so proud to showcase the next wave of talent in cancer research at our ‘Cancer Researchers to watch’ early career showcase yesterday and this morning. #EACR2026
June 8, 2026 at 9:05 AM
We’re so proud to showcase the next wave of talent in cancer research at our ‘Cancer Researchers to watch’ early career showcase yesterday and this morning. #EACR2026
Reposted by George Sflomos
Today is the start of #EACR2026! We’re excited to welcome participants from over 70 countries to our Annual Congress here in Budapest. Find the programme at 2026.eacr.org and don’t forget to use the hashtag!
June 8, 2026 at 9:30 AM
Today is the start of #EACR2026! We’re excited to welcome participants from over 70 countries to our Annual Congress here in Budapest. Find the programme at 2026.eacr.org and don’t forget to use the hashtag!
Reposted by George Sflomos
As we open the #EACR2026 Congress Marisol Soengas @msmelanoma.bsky.social delivers a moving talk on the importance of the patient perspective in research.
June 8, 2026 at 2:38 PM
As we open the #EACR2026 Congress Marisol Soengas @msmelanoma.bsky.social delivers a moving talk on the importance of the patient perspective in research.
Reposted by George Sflomos
Our early career and student participants are learning from cancer research leaders this afternoon on topics from ‘How to build your own network’ to ‘How to make smart career choices’! Fantastic to see all the new connections being made at #EACR2026
June 9, 2026 at 1:06 PM
Our early career and student participants are learning from cancer research leaders this afternoon on topics from ‘How to build your own network’ to ‘How to make smart career choices’! Fantastic to see all the new connections being made at #EACR2026
Reposted by George Sflomos
Charles Swanton delivers the Mike Price Award Lecture on ‘Cancer Promotion and Preventing Pathologies of Ageing’ this afternoon at #EACR2026 👏
June 9, 2026 at 4:24 PM
Charles Swanton delivers the Mike Price Award Lecture on ‘Cancer Promotion and Preventing Pathologies of Ageing’ this afternoon at #EACR2026 👏
Reposted by George Sflomos
We’re delighted to have awarded 52 Travel Grants to help researchers from 26 countries to attend #EACR2026 – congratulations to all of you!
June 10, 2026 at 10:24 AM
We’re delighted to have awarded 52 Travel Grants to help researchers from 26 countries to attend #EACR2026 – congratulations to all of you!
Reposted by George Sflomos
Today’s Plenary Session “From Bench to Bedside and Back” features talks from Johanna A Joyce, Yardena Samuels, Gideon Bollag, Darrin Stuart, and Keith Flaherty. #EACR2026
June 10, 2026 at 4:56 PM
Today’s Plenary Session “From Bench to Bedside and Back” features talks from Johanna A Joyce, Yardena Samuels, Gideon Bollag, Darrin Stuart, and Keith Flaherty. #EACR2026
Reposted by George Sflomos
Don't forget that the EACR-Worldwide Cancer Research Collaboration Fellowships are a new initiative this year. If you make a new research connection at EACR 2026, apply for funding to continue the collaboration with an in-person visit!
Apply by 3 Sep 2026 eacr.org/collaboratio...
Apply by 3 Sep 2026 eacr.org/collaboratio...
June 4, 2026 at 8:46 AM
Don't forget that the EACR-Worldwide Cancer Research Collaboration Fellowships are a new initiative this year. If you make a new research connection at EACR 2026, apply for funding to continue the collaboration with an in-person visit!
Apply by 3 Sep 2026 eacr.org/collaboratio...
Apply by 3 Sep 2026 eacr.org/collaboratio...
Reposted by George Sflomos
We're counting down the days until #EACR2026 in Budapest!
With participants from over 70 countries, intentional programming, and several networking events - you're bound to leave inspired for the next stage of your research.
There's still time to join us! Find more information at 2026.eacr.org
With participants from over 70 countries, intentional programming, and several networking events - you're bound to leave inspired for the next stage of your research.
There's still time to join us! Find more information at 2026.eacr.org
June 1, 2026 at 8:46 AM
We're counting down the days until #EACR2026 in Budapest!
With participants from over 70 countries, intentional programming, and several networking events - you're bound to leave inspired for the next stage of your research.
There's still time to join us! Find more information at 2026.eacr.org
With participants from over 70 countries, intentional programming, and several networking events - you're bound to leave inspired for the next stage of your research.
There's still time to join us! Find more information at 2026.eacr.org
Reposted by George Sflomos
Nominations are now open for the:
🏆Pezcoller-Marina Larcher Fogazzaro-EACR Women in Cancer Research Award
🏆Pezcoller Foundation-EACR Translational Cancer Researcher Award
Nominating someone is a great way to recognise and celebrate their achievements.
For more information: eacr.org/pezcoller-fo...
🏆Pezcoller-Marina Larcher Fogazzaro-EACR Women in Cancer Research Award
🏆Pezcoller Foundation-EACR Translational Cancer Researcher Award
Nominating someone is a great way to recognise and celebrate their achievements.
For more information: eacr.org/pezcoller-fo...
June 2, 2026 at 8:46 AM
Nominations are now open for the:
🏆Pezcoller-Marina Larcher Fogazzaro-EACR Women in Cancer Research Award
🏆Pezcoller Foundation-EACR Translational Cancer Researcher Award
Nominating someone is a great way to recognise and celebrate their achievements.
For more information: eacr.org/pezcoller-fo...
🏆Pezcoller-Marina Larcher Fogazzaro-EACR Women in Cancer Research Award
🏆Pezcoller Foundation-EACR Translational Cancer Researcher Award
Nominating someone is a great way to recognise and celebrate their achievements.
For more information: eacr.org/pezcoller-fo...
Reposted by George Sflomos
The EACR Congress is coming to Hungary in June!
Join the wider cancer research community in Budapest for four days of fantastic science and networking opportunities at #EACR2026 🤝
Register before 18 May to get the regular rate! 👀
Learn more here ➡️ 2026.eacr.org
Join the wider cancer research community in Budapest for four days of fantastic science and networking opportunities at #EACR2026 🤝
Register before 18 May to get the regular rate! 👀
Learn more here ➡️ 2026.eacr.org
April 30, 2026 at 8:46 AM
The EACR Congress is coming to Hungary in June!
Join the wider cancer research community in Budapest for four days of fantastic science and networking opportunities at #EACR2026 🤝
Register before 18 May to get the regular rate! 👀
Learn more here ➡️ 2026.eacr.org
Join the wider cancer research community in Budapest for four days of fantastic science and networking opportunities at #EACR2026 🤝
Register before 18 May to get the regular rate! 👀
Learn more here ➡️ 2026.eacr.org
Reposted by George Sflomos
Our Cancer Genomics conference is happening today with an introduction by Carlos Caldas, Chair of the Scientific Programme Committee!
May 12, 2026 at 11:12 AM
Our Cancer Genomics conference is happening today with an introduction by Carlos Caldas, Chair of the Scientific Programme Committee!
Reposted by George Sflomos
Introducing the EACR-Worldwide Cancer Research Collaboration Fellowships!
If you make a new research connection at the EACR 2026 Congress in Budapest, why not apply for funding for an in-person visit?
Applications due by 03 September 2026
Apply here: eacr.org/collaboratio...
If you make a new research connection at the EACR 2026 Congress in Budapest, why not apply for funding for an in-person visit?
Applications due by 03 September 2026
Apply here: eacr.org/collaboratio...
May 22, 2026 at 8:46 AM
Introducing the EACR-Worldwide Cancer Research Collaboration Fellowships!
If you make a new research connection at the EACR 2026 Congress in Budapest, why not apply for funding for an in-person visit?
Applications due by 03 September 2026
Apply here: eacr.org/collaboratio...
If you make a new research connection at the EACR 2026 Congress in Budapest, why not apply for funding for an in-person visit?
Applications due by 03 September 2026
Apply here: eacr.org/collaboratio...
Excited to start at HUG in Geneva, bridging translational oncology and radiotherapy!
May 2, 2026 at 5:28 AM
Excited to start at HUG in Geneva, bridging translational oncology and radiotherapy!
Reposted by George Sflomos
How can researchers and patient advocates actually work together — and what does meaningful collaboration look like in practice?
Episode 31 of The Cancer Researcher Podcast tackles this topic head-on.
Listen now: magazine.eacr.org/an-open-foru... 🎧
Episode 31 of The Cancer Researcher Podcast tackles this topic head-on.
Listen now: magazine.eacr.org/an-open-foru... 🎧
April 14, 2026 at 11:02 AM
How can researchers and patient advocates actually work together — and what does meaningful collaboration look like in practice?
Episode 31 of The Cancer Researcher Podcast tackles this topic head-on.
Listen now: magazine.eacr.org/an-open-foru... 🎧
Episode 31 of The Cancer Researcher Podcast tackles this topic head-on.
Listen now: magazine.eacr.org/an-open-foru... 🎧
Reposted by George Sflomos
PI3K Inhibition in Combination with Tamoxifen in Patients with Metastatic HR+/HER2− Breast Cancer!
This started with the RATHER project, which was part of the EU's FP VII funded (cordis.europa.eu/project/id/2...)
@caldaslab.bsky.social always walked the walk!
aacrjournals.org/clincancerre...
This started with the RATHER project, which was part of the EU's FP VII funded (cordis.europa.eu/project/id/2...)
@caldaslab.bsky.social always walked the walk!
aacrjournals.org/clincancerre...
PI3K Inhibition in Combination with Tamoxifen in Patients with Metastatic HR+/HER2− Breast Cancer: Clinical and Circulating Tumor DNA Results
AbstractPurpose:. To determine the safety and efficacy of taselisib, a selective PI3K inhibitor, in combination with tamoxifen.Patients and Methods:. POSEIDON is a phase II, randomized, placebo-contro...
aacrjournals.org
April 13, 2026 at 12:49 PM
PI3K Inhibition in Combination with Tamoxifen in Patients with Metastatic HR+/HER2− Breast Cancer!
This started with the RATHER project, which was part of the EU's FP VII funded (cordis.europa.eu/project/id/2...)
@caldaslab.bsky.social always walked the walk!
aacrjournals.org/clincancerre...
This started with the RATHER project, which was part of the EU's FP VII funded (cordis.europa.eu/project/id/2...)
@caldaslab.bsky.social always walked the walk!
aacrjournals.org/clincancerre...
Reposted by George Sflomos
We're researching relentlessly now. For a future where no one dies of breast cancer. 🔬
We're here with support now. Until the day you no longer need us. ❤️
We're demanding change now. So everyone can get the best treatment. 📢
We're here with support now. Until the day you no longer need us. ❤️
We're demanding change now. So everyone can get the best treatment. 📢
March 23, 2026 at 12:59 PM
We're researching relentlessly now. For a future where no one dies of breast cancer. 🔬
We're here with support now. Until the day you no longer need us. ❤️
We're demanding change now. So everyone can get the best treatment. 📢
We're here with support now. Until the day you no longer need us. ❤️
We're demanding change now. So everyone can get the best treatment. 📢
Terrific study! This review will be a super useful tool to people working with preclinical models!
oncodaily.com/voices/patri...
oncodaily.com/voices/patri...
Patrick Aouad: Major Preclinical Models Used to Study Breast Cancer Metastasis - OncoDaily
Patrick Aouad: Major Preclinical Models Used to Study Breast Cancer Metastasis / Berthe Hayar, cancer, Cathrin Brisken, Ciara Metcalfe, George Sflomos, Karim
oncodaily.com
March 22, 2026 at 7:09 PM
Terrific study! This review will be a super useful tool to people working with preclinical models!
oncodaily.com/voices/patri...
oncodaily.com/voices/patri...
Reposted by George Sflomos
You have until 16 March to apply for travel grants and submit abstracts for Cancer Genomics, Multiomics and Computational Biology!
This extremely popular EACR conference showcases the latest breakthroughs in this exciting field with a cutting-edge programme.
This extremely popular EACR conference showcases the latest breakthroughs in this exciting field with a cutting-edge programme.
Introduction | Cancer Genomics, Multiomics and Computational Biology | The European Association for Cancer Research
Key dates
eacr.org
February 23, 2026 at 9:46 AM
You have until 16 March to apply for travel grants and submit abstracts for Cancer Genomics, Multiomics and Computational Biology!
This extremely popular EACR conference showcases the latest breakthroughs in this exciting field with a cutting-edge programme.
This extremely popular EACR conference showcases the latest breakthroughs in this exciting field with a cutting-edge programme.
Reposted by George Sflomos
Who should attend our FREE public webinar with the @CGIclinics project?
👉️ Clinical molecular biologists & pathologists
👉️ Oncologists in precision medicine & phase I clinical trials
👉️ Researchers in precision oncology & cancer genomics
👉️ Bioinformaticians in clinical oncology labs
buff.ly/KQL1KDS
👉️ Clinical molecular biologists & pathologists
👉️ Oncologists in precision medicine & phase I clinical trials
👉️ Researchers in precision oncology & cancer genomics
👉️ Bioinformaticians in clinical oncology labs
buff.ly/KQL1KDS
March 11, 2026 at 9:46 AM
Who should attend our FREE public webinar with the @CGIclinics project?
👉️ Clinical molecular biologists & pathologists
👉️ Oncologists in precision medicine & phase I clinical trials
👉️ Researchers in precision oncology & cancer genomics
👉️ Bioinformaticians in clinical oncology labs
buff.ly/KQL1KDS
👉️ Clinical molecular biologists & pathologists
👉️ Oncologists in precision medicine & phase I clinical trials
👉️ Researchers in precision oncology & cancer genomics
👉️ Bioinformaticians in clinical oncology labs
buff.ly/KQL1KDS
Super useful tool to people working with preclinical models!
Terrific work @patrickaouad.bsky.social summarising decades of research to provide a review on the major preclinical models used to study breast cancer metastasis.
Terrific work @patrickaouad.bsky.social summarising decades of research to provide a review on the major preclinical models used to study breast cancer metastasis.
I am really excited to share that our review on preclinical models of breast cancer metastasis is out in npj Breast Cancer! We provide a comprehensive overview of the major preclinical models used to study breast cancer metastasis www.nature.com/articles/s41...
March 17, 2026 at 6:18 AM
Super useful tool to people working with preclinical models!
Terrific work @patrickaouad.bsky.social summarising decades of research to provide a review on the major preclinical models used to study breast cancer metastasis.
Terrific work @patrickaouad.bsky.social summarising decades of research to provide a review on the major preclinical models used to study breast cancer metastasis.